ARGA Investment Management LP Grows Holdings in Humana Inc. $HUM

ARGA Investment Management LP raised its holdings in shares of Humana Inc. (NYSE:HUMFree Report) by 3.1% in the 1st quarter, Holdings Channel reports. The firm owned 230,077 shares of the insurance provider’s stock after purchasing an additional 7,013 shares during the quarter. Humana accounts for 1.3% of ARGA Investment Management LP’s holdings, making the stock its 16th biggest holding. ARGA Investment Management LP’s holdings in Humana were worth $39,893,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in the stock. Montag A & Associates Inc. grew its holdings in shares of Humana by 1,880.0% in the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after purchasing an additional 94 shares during the last quarter. CoreCap Advisors LLC lifted its holdings in Humana by 54.4% during the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after buying an additional 37 shares in the last quarter. Fideuram Asset Management Ireland dac purchased a new stake in Humana in the 4th quarter valued at about $27,000. Reflection Asset Management bought a new position in Humana in the 4th quarter worth about $29,000. Finally, Rosenberg Matthew Hamilton grew its stake in Humana by 136.0% in the 4th quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock worth $30,000 after acquiring an additional 68 shares in the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms have recently weighed in on HUM. Oppenheimer raised shares of Humana from an “outperform” rating to an “outperform” rating in a research note on Wednesday, May 20th. Bank of America raised their price objective on Humana from $340.00 to $380.00 and gave the stock a “neutral” rating in a report on Wednesday, June 24th. Seaport Research Partners lowered Humana to a “neutral” rating in a research report on Wednesday, May 20th. The Goldman Sachs Group upped their target price on Humana from $158.00 to $195.00 and gave the stock a “sell” rating in a report on Thursday, April 30th. Finally, Weiss Ratings raised Humana from a “hold (c-)” rating to a “hold (c)” rating in a research report on Monday, June 29th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, sixteen have issued a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $303.74.

Check Out Our Latest Research Report on HUM

Humana Price Performance

NYSE HUM opened at $392.76 on Friday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77. The firm’s 50 day moving average price is $338.80 and its 200-day moving average price is $255.19. Humana Inc. has a 52-week low of $163.11 and a 52-week high of $415.00. The company has a market cap of $47.15 billion, a PE ratio of 42.01, a P/E/G ratio of 2.27 and a beta of 0.71.

Humana (NYSE:HUMGet Free Report) last issued its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, topping analysts’ consensus estimates of $9.97 by $0.34. The company had revenue of $39.65 billion during the quarter, compared to the consensus estimate of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. Humana’s revenue for the quarter was up 23.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. Sell-side analysts forecast that Humana Inc. will post 9.03 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Humana’s payout ratio is presently 37.86%.

About Humana

(Free Report)

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

Further Reading

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUMFree Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.